About

Dr. Ahmed Eraky is a leading urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for kidney, prostate, and bladder cancers. His major contributions include landmark multicenter studies comparing surgical approaches, such as his highly cited 2020 paper on retroperitoneal versus transperitoneal robotic partial nephrectomy (53 citations), which has helped refine operative techniques. Dr. Eraky has also demonstrated the critical role of surgical experience in optimizing outcomes, analyzing over 2,500 patients to show how prior training impacts robot-assisted partial nephrectomy results (28 citations). His research extends to benign prostatic hyperplasia, where he compared en-bloc holmium laser enucleation with robot-assisted simple prostatectomy, and to bladder cancer, with long-term analyses of robot-assisted radical cystectomy for non-muscle-invasive disease. More recently, he has explored same-day discharge protocols and immunotherapy-based neoadjuvant treatments. With over a dozen publications in high-impact journals, Dr. Eraky’s work consistently provides evidence-based guidance for urologists worldwide, shaping best practices in minimally invasive urologic oncology.

Research Focus

Key Achievements

6
H-Index
13
Papers
129
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Retroperitoneal Versus Transperitoneal Robotic Partial Nephrectomy: A Multicenter Matched-pair Analysis
53 citations · 2020
📈 Most Prolific Year: 2025 (8 Papers)
🤝 Key Collaborators: 153
🏛 Institutions: Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, University Hospital Schleswig-Holstein, Mount Sinai Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago